Clinical Research Advantage, Inc./Simon Williamson Clinic

Birmingham, Alabama 35211

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Migraine, With or Without Aura

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early